Collection 專利 [0/63] 期刊論文 [147/147] 會議論文/會議摘要 [33/51] Siblings 伍素瑩 [53/74] 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 陳炯東 [184/268] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:21(8.05%) 含全文筆數:180(68.97%) 文件下載次數統計 下載大於0次:180(100.00%) 下載大於100次:170(94.44%) 檔案下載總次數:106377(1.82%) 最後更新時間: 2025-04-19 12:41 Top Upload Loading... Top Download Loading... Recent Submissions KIF2C promotes paclitaxel resistanc... Identification and biological evalu... 吡咯烷化合物 단백질 키나아제 억제제로서의 융합 다환 화합물 做為蛋白激酶抑制劑的稠合多環化合物 作为蛋白激酶抑制剂的稠合多环化合物 作爲蛋白激酶抑制劑的稠合多環化合物 Fused bicyclic pyrimidine compounds... Fused bicyclic pyrimidine compounds... Fused bicyclic pyrimidine compounds...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-50 of 261. (11 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2022-03-11	以雜環化合物作為激酶抑制劑的治療用途	TWI757722/2022-03-11
2022-01-21	Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma	Journal of Biomedical Science. 2022 Jan 21;29:Article number 5.
2021-11-15	Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization	European Journal of Medicinal Chemistry. 2021 Nov 15;224:Article number 113673.
2021-10-14	Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model	Journal of Medicinal Chemistry. 2021 Oct 14;64(19):14477-14497.
2021-07-16	Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens	Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
2021-04-16	Development of a robust scale-up synthetic route for BPR1K871: A clinical candidate for the treatment of acute myeloid leukemia and solid tumors	Organic Process Research and Development. 2021 Apr 16;25(4):817-830.
2021-04-13	Chlorinated briarane diterpenoids from octocoral Briareum stechei (Kükenthal, 1908)	Tetrahedron Letters. 2021 Apr 13;69:Article number 152976.
2021-02-22	Mimicking H3 substrate arginine in the design of G9a lysine methyltransferase inhibitors for cancer therapy: A computational study for structure-based drug design	ACS Omega. 2021 Feb 22;6(9):6100-6111.
2021-01-31	Briarenols W-Z: Chlorine-containing polyoxygenated briaranes from octocoral briareum stechei (Kükenthal, 1908)	Marine Drugs. 2021 Jan 31;19(2):Article number 77.
2021-01-15	One-pot synthesis of dibenzo[b,f]oxepines and total synthesis of bauhinoxepin C	Journal of Organic Chemistry. 2021 Jan 15;86(2):1955-1963.
2021-01	Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors	Chemical Biology and Drug Design. 2021 Jan;97(1):51-66.
2020-12-10	Tumor-agnostic inhibitors in oncology: A new phase for precision medicine	Journal of the Chinese Chemical Society. 2020 Dec 10;67(12):2216-2224.
2020-08	Design of a potent anticancer lead inspired by natural products from traditional Indian medicine	Journal of Biomolecular Structure and Dynamics. 2020 Aug;38(12):3563-3577.
2020-07	Design of drug-like hepsin inhibitors against prostate cancer and kidney stones	Acta Pharmaceutica Sinica B. 2020 Jul;10(7):1309-1320.
2020-05	Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors	Bioorganic Chemistry. 2020 May;98:Article number 103689.
2020-03-01	A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis	Cancer Letters. 2020 Mar 1;472:97-107.
2020-01	Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening	Biochimie. 2020 Jan;168:220-230.
2019-12	Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry	Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
2019-11-27	Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-10-08	Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity	Advanced Therapeutics. 2019 Oct 8;2(12):Article number 1900105.
2019-10	Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer	Annals of Oncology. 2019 Oct;30(Suppl. 5):789.
2019-10	The molecular mechanisms of EpCAM in regulating tumor progression and development of anti-EpCAM antibodies for colon cancer diagnosis and therapy	Annals of Oncology. 2019 Oct;30(Suppl. 5):786.
2019-07-03	Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: A molecular dynamics study	Journal of Biomolecular Structure and Dynamics. 2019 Jul 3;37(10):2581-2592.
2019-07	Dual Kit/Aur inhibitors as chemosensitizing agents for the treatment of melanoma: Design, synthesis, docking studies and functional investigation	Scientific Reports. 2019 Jul;9:Article number 9943.
2019-05-29	Insights for the design of protein lysine methyltransferase G9a inhibitors	Future Medicinal Chemistry. 2019 May 29;11(9):993-1014.

Showing items 26-50 of 261. (11 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page